Hawaii HB820 requires health insurers to cover continuous glucose monitors for individuals diagnosed with diabetes.
Hawaii HB820 mandates that all health insurers, including Medicaid managed care programs, cover continuous glucose monitors and related supplies for individuals diagnosed with diabetes. This requirement applies to all policies, contracts, plans, or agreements issued or renewed in the state after December 31, 2025. The bill aims to improve health outcomes by providing real-time data on blood glucose levels, reducing hypoglycemic episodes, and lowering A1C levels.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.